Novavax Announces Proposed $125 Million Public Offering of Com...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Dec. 14, 2022 /PRNewswire-Asianet/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwritten public offering to sell up to $125 million of its c...
Authors: LATEST ASIANET NEWS RELEASES